Three Anticoagulants, Three Labs, Three Reversals
Three parallel tracks from a simplified clotting cascade through a blocking bar at each drug's true point of action, past a monitoring node, to a reversal vial, with a dashed delay gap on the warfarin track.
| UNFRACTIONATED HEPARIN | WARFARIN | DIRECT ORAL ANTICOAGULANTS | |
|---|---|---|---|
| Mechanism | potentiates antithrombin, inactivating thrombin and factor Xa | vitamin K antagonist; blocks synthesis of factors II, VII, IX and X | dabigatran inhibits thrombin directly; apixaban and rivaroxaban inhibit factor Xa directly |
| Route | intravenous or subcutaneous | oral | oral |
| Onset | immediate by the intravenous route | delayed; full effect takes several days | rapid, within hours |
| Monitored by | activated partial thromboplastin time or anti-factor Xa activity, plus platelet count | prothrombin time and the international normalized ratio | no routine coagulation testing; renal function instead |
| Reversal | protamine sulfate | phytonadione, with four-factor prothrombin complex concentrate for major bleeding | idarucizumab for dabigatran; andexanet alfa for the factor Xa inhibitors |
| Classic error | continuing the infusion while the platelet count falls | expecting an immediate effect and stacking doses | assuming no monitoring means no risk, and missing declining kidney function |
| Teaching point | report bleeding gums, black stools, or new bruising | keep vitamin K intake consistent, not absent; never double a missed dose | do not stop without contacting the prescriber; report any fall or head strike |
Why warfarin is slow
Warfarin blocks the synthesis of new clotting factors but does nothing to the factors already circulating. Those must clear on their own, which takes days and is the entire reason bridging with a heparin exists. A patient who feels no different on day two is not a patient whose drug has failed.
The clinical sentence. For a patient taking warfarin for atrial fibrillation, the prescriber commonly targets an international normalized ratio of 2 to 3, and the nurse reports a result outside the ordered range rather than adjusting the dose independently → BOOK 07 · P5.
Watch outa falling platelet count on heparin is a reason to stop, not a reason to keep going. Heparin-induced thrombocytopenia paradoxically causes clotting, and continuing the drug because the patient is not bleeding is the error the item is built around.
Margin noteconsistent greens, not no greens. Tick box: can I name all three reversals?
No infusion rate, unit math, or titration appears here → BOOK 06. No reference range table → BOOK 07. Anticoagulation inside acute coronary syndrome or atrial fibrillation management → BOOK 08.
TakeawayEach anticoagulant carries its own monitoring test and its own reversal agent, and confusing the pairs is a bleeding event.